| LRRK2 regulates synaptic vesicle endocytosis N Shin, H Jeong, J Kwon, HY Heo, JJ Kwon, HJ Yun, CH Kim, BS Han, ... Experimental cell research 314 (10), 2055-2065, 2008 | 421 | 2008 |
| PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy S Kawajiri, S Saiki, S Sato, F Sato, T Hatano, H Eguchi, N Hattori FEBS letters 584 (6), 1073-1079, 2010 | 294 | 2010 |
| Identification of novel biomarkers for Parkinson's disease by metabolomic technologies T Hatano, S Saiki, A Okuzumi, RP Mohney, N Hattori Journal of Neurology, Neurosurgery & Psychiatry 87 (3), 295-301, 2016 | 262 | 2016 |
| Leucine-rich repeat kinase 2 associates with lipid rafts T Hatano, S Kubo, S Imai, M Maeda, K Ishikawa, Y Mizuno, N Hattori Human molecular genetics 16 (6), 678-690, 2007 | 253 | 2007 |
| Propagative α-synuclein seeds as serum biomarkers for synucleinopathies A Okuzumi, T Hatano, G Matsumoto, S Nojiri, S Ueno, Y Imamichi-Tatano, ... Nature medicine 29 (6), 1448-1455, 2023 | 169 | 2023 |
| Progress in the pathogenesis and genetics of Parkinson's disease Y Mizuno, N Hattori, S Kubo, S Sato, K Nishioka, T Hatano, H Tomiyama, ... Philosophical Transactions of the Royal Society B: Biological Sciences 363 …, 2008 | 164 | 2008 |
| Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations K Sato, T Hatano, K Yamashiro, M Kagohashi, K Nishioka, N Izawa, ... Movement disorders: official journal of the Movement Disorder Society 21 (9 …, 2006 | 161 | 2006 |
| Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease K Kamagata, T Hatano, A Okuzumi, Y Motoi, O Abe, K Shimoji, K Kamiya, ... European radiology 26, 2567-2577, 2016 | 146 | 2016 |
| Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease S Saiki, T Hatano, M Fujimaki, KI Ishikawa, A Mori, Y Oji, A Okuzumi, ... Scientific reports 7 (1), 7328, 2017 | 138 | 2017 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 137 | 2023 |
| Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease T Hatano, S Kubo, S Sato, N Hattori Journal of neurochemistry 111 (5), 1075-1093, 2009 | 137 | 2009 |
| A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging K Kamagata, H Tomiyama, T Hatano, Y Motoi, O Abe, K Shimoji, ... Neuroradiology 56, 251-258, 2014 | 131 | 2014 |
| Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ... The Lancet Neurology 20 (3), 182-192, 2021 | 130 | 2021 |
| MR biomarkers of degenerative brain disorders derived from diffusion imaging C Andica, K Kamagata, T Hatano, Y Saito, K Ogaki, N Hattori, S Aoki Journal of Magnetic Resonance Imaging 52 (6), 1620-1636, 2020 | 130 | 2020 |
| Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks A Yoritaka, Y Shimo, M Takanashi, J Fukae, T Hatano, T Nakahara, ... Parkinsonism & related disorders 19 (8), 725-731, 2013 | 123 | 2013 |
| Gray matter abnormalities in idiopathic P arkinson's disease: Evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging K Kamagata, A Zalesky, T Hatano, R Ueda, MA Di Biase, A Okuzumi, ... Human brain mapping 38 (7), 3704-3722, 2017 | 117 | 2017 |
| A metabolic profile of polyamines in parkinson disease: A promising biomarker S Saiki, Y Sasazawa, M Fujimaki, K Kamagata, N Kaga, H Taka, Y Li, ... Annals of neurology 86 (2), 251-263, 2019 | 107 | 2019 |
| Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease M Fujimaki, S Saiki, Y Li, N Kaga, H Taka, T Hatano, KI Ishikawa, Y Oji, ... Neurology 90 (5), e404-e411, 2018 | 104 | 2018 |
| VPS35 mutation in Japanese patients with typical Parkinson's disease M Ando, M Funayama, Y Li, K Kashihara, Y Murakami, N Ishizu, C Toyoda, ... Movement disorders 27 (11), 1413-1417, 2012 | 102 | 2012 |
| Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease Y Oji, T Hatano, SI Ueno, M Funayama, K Ishikawa, A Okuzumi, S Noda, ... Brain 143 (4), 1190-1205, 2020 | 97 | 2020 |
